Leicester, United Kingdom

Michael Danny Burke


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Leicester LE7 9HL, GB (2002)
  • Leicester, GB (2001 - 2004)

Company Filing History:


Years Active: 2001-2004

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Michael Danny Burke: Innovator in Drug Release Technologies

Introduction

Michael Danny Burke is a notable inventor based in Leicester, GB, recognized for his contributions to the field of drug release technologies. With a total of four patents to his name, Burke has made significant strides in the development of prodrugs that enhance therapeutic efficacy.

Latest Patents

Among his latest innovations, Burke has developed patents focused on hydroxylation activated drug release. His work involves prodrugs whose aromatic oxidation, particularly enzymatic aromatic hydroxylation, leads to the activation and release of a drug moiety. This technology is particularly relevant for anti-tumor prodrugs that are specifically activated by the hydroxylation activity of the P-450 enzyme CYP1B1. Additionally, he has created methods for detecting aromatic oxidation activity, further advancing the field of drug delivery systems.

Career Highlights

Throughout his career, Burke has worked with various institutions, including De Montfort University, where he has likely contributed to research and development in pharmacology and drug design. His innovative approaches have positioned him as a key figure in the exploration of enzymatic activation in drug therapies.

Collaborations

Burke has collaborated with notable individuals in his field, including Lawrence Hylton Patterson and Gerard Andrew Potter. These partnerships have likely facilitated the advancement of his research and the successful development of his patented technologies.

Conclusion

Michael Danny Burke's work in hydroxylation activated drug release represents a significant advancement in the field of pharmaceuticals. His innovative patents and collaborations highlight his commitment to improving drug delivery systems for better therapeutic outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…